↓ Skip to main content

Dove Medical Press

Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

Overview of attention for article published in Journal of Hepatocellular Carcinoma, April 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#1 of 206)
  • High Attention Score compared to outputs of the same age (99th percentile)

Mentioned by

news
75 news outlets
twitter
4 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
42 Mendeley